Dung‐Tsa Chen

University of Maryland, Baltimore — United States

Medicine · Health Sciences

36h-index4.8kcitations323works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(55), Pancreatic and Hepatic Oncology Research(52), Immunotherapy and Immune Responses(45), Gene expression and cancer classification(44), Multiple Myeloma Research and Treatments(42)

Publications322 total

Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma
Communications Medicine·2025Open Access
Timing of Durvalumab Consolidation and Survival in Non–Small Cell Lung Cancer: A Population-Based Analysis
JCO Oncology Practice·2025
Pre-averaging fractional processes contaminated by noise, with an application to turbulence
Journal of Applied Probability·2025
Initial results from a phase 2 study of cladribine, cytarabine, and granulocyte-colony stimulating factor with gemtuzumab ozogamicin (CLAG-GO) for the treatment of patients with relapsed/refractory acute myeloid leukemia
Blood·2025
Relationship between PD-L1 Expression and Outcomes of Salvage Treatment Following Durvalumab Consolidation
Clinical Lung Cancer·2025
Supplementary Table S5 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Table S3 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S2 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S6 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Table S1 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S4 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S5 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S1 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S7 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Data from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Table S2 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Table S4 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S3 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
2025Open Access
Supplementary Figure S2 from Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma
2025Open Access
Supplementary Figure S4 from Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma
2025Open Access
page 1 of 17Next →

Frequent Co-authors

Mokenge P. Malafa(16), Domenico Coppola(11), William J. Fulp(10), Eric B. Haura(8), Barbara A. Centeno(8), Timothy J. Yeatman(8), Pamela J. Hodul(7), Scott Antonia(6), Ardeshir Hakam(6), José M. Pimiento(6), Ben Creelan(5), Alberto Chiappori(5), Tawee Tanvetyanon(5), Sean Yoder(5), Kazim Husain(5), Ram Thapa(5), Jamie K. Teer(4), Sungjune Kim(4), Yin Xiong(4), Robert M. Wenham(4)